Search research articles
Contact Us
Filters
Showing results (21-30 of 44) with videos related to
Page
of 5
Sort By:
European Urology
|
June 22, 2000
Stage migration in clinically localized prostate cancer
J Noldus, M Graefen, A Haese, et al.
Der Urologe. Ausg. A
|
April 24, 2001
[Nerve-sparing radical retropubic prostatectomy. Results of a patient survey]
J Noldus, U Michl, M Graefen, et al.
The Journal of Urology
|
February 7, 2001
Human glandular kallikrein 2: a potential serum marker for predicting the organ confined versus non-organ confined growth of prostate cancer
A Haese, C Becker, J Noldus, et al.
BJU International
|
March 27, 2003
Differences in biopsy features between prostate cancers located in the transition and peripheral zone
H Augustin, A Erbersdobler, M Graefen, et al.
Anticancer Research
|
May 1, 2001
Analysis of molecular isoforms of PSA and their ratios in men with PSA-relapse after radical prostatectomy
P Hammerer, M Graefen, R P Henke, et al.
The Journal of Urology
|
November 24, 1999
Significance and metabolism of complexed and noncomplexed prostate specific antigen forms, and human glandular kallikrein 2 in clinically localized prostate cancer before and after radical prostatectomy
H Lilja, A Haese, T Björk, et al.
Urology
|
March 24, 1998
Incidence of positive surgical margins after biopsy-selected nerve-sparing radical prostatectomy
M Graefen, P Hammerer, U Michl, et al.
The Prostate
|
October 3, 2001
Human glandular kallikrein 2 levels in serum for discrimination of pathologically organ-confined from locally-advanced prostate cancer in total PSA-levels below 10 ng/ml
A Haese, M Graefen, T Steuber, et al.
Annales D'Urologie
|
March 7, 2007
[Technical aspects of nerve sparing during retropubic prostatectomy]
J Walz, M Graefen, U H G Michl, et al.
European Urology
|
June 12, 1999
Early prostate-specific antigen relapse after radical retropubic prostatectomy: prediction on the basis of preoperative and postoperative tumor characteristics
M Graefen, J Noldus, U Pichlmeier, et al.
Page
of 5
Search research articles
Search
Showing results (21-30 of 44) with videos related to
Sort By:
Page
of 5
European Urology
|
June 22, 2000
Stage migration in clinically localized prostate cancer
J Noldus, M Graefen, A Haese, et al.
Der Urologe. Ausg. A
|
April 24, 2001
[Nerve-sparing radical retropubic prostatectomy. Results of a patient survey]
J Noldus, U Michl, M Graefen, et al.
The Journal of Urology
|
February 7, 2001
Human glandular kallikrein 2: a potential serum marker for predicting the organ confined versus non-organ confined growth of prostate cancer
A Haese, C Becker, J Noldus, et al.
BJU International
|
March 27, 2003
Differences in biopsy features between prostate cancers located in the transition and peripheral zone
H Augustin, A Erbersdobler, M Graefen, et al.
Anticancer Research
|
May 1, 2001
Analysis of molecular isoforms of PSA and their ratios in men with PSA-relapse after radical prostatectomy
P Hammerer, M Graefen, R P Henke, et al.
The Journal of Urology
|
November 24, 1999
Significance and metabolism of complexed and noncomplexed prostate specific antigen forms, and human glandular kallikrein 2 in clinically localized prostate cancer before and after radical prostatectomy
H Lilja, A Haese, T Björk, et al.
Urology
|
March 24, 1998
Incidence of positive surgical margins after biopsy-selected nerve-sparing radical prostatectomy
M Graefen, P Hammerer, U Michl, et al.
The Prostate
|
October 3, 2001
Human glandular kallikrein 2 levels in serum for discrimination of pathologically organ-confined from locally-advanced prostate cancer in total PSA-levels below 10 ng/ml
A Haese, M Graefen, T Steuber, et al.
Annales D'Urologie
|
March 7, 2007
[Technical aspects of nerve sparing during retropubic prostatectomy]
J Walz, M Graefen, U H G Michl, et al.
European Urology
|
June 12, 1999
Early prostate-specific antigen relapse after radical retropubic prostatectomy: prediction on the basis of preoperative and postoperative tumor characteristics
M Graefen, J Noldus, U Pichlmeier, et al.
Page
of 5